Abstract
Pulmonary complications of AIDS are one of the major causes of morbidity and mortality in HIVinfected individuals, and are often direct indicators of enhanced progression to an AIDS-defining illness. HIV can be detected in the lung during asymptomatic disease, as well as during the advanced stages of AIDS. With prolonged survival of HIV-infected patients, non-infectious pulmonary complications are becoming more common and can lead to respiratory compromise and failure. The pathogenesis of non-infectious pulmonary complications, following HIV infection is not fully understood, and the role that HIV-induced immunosuppression plays in the development of these complications is not known. In this review, we will discuss non-infectious pulmonary complications of HIV infection, focusing on HIV-associated malignancies of the lung, inflammatory disorders, pulmonary hypertension and the effect of antiretroviral therapy on the incidence of these diseases. The possible role that HIV plays in the pathogenesis of these pulmonary disorders is also addressed.
Keywords: hiv, pulmonary complications, lung malignancies, inflammatory disorders
Current HIV Research
Title: Is HIV Involved in the Pathogenesis of Non-Infectious Pulmonary Complications in Infected Patients?
Volume: 1 Issue: 4
Author(s): Georgette D. Kanmogne, Ronald C. Kennedy and Paula Grammas
Affiliation:
Keywords: hiv, pulmonary complications, lung malignancies, inflammatory disorders
Abstract: Pulmonary complications of AIDS are one of the major causes of morbidity and mortality in HIVinfected individuals, and are often direct indicators of enhanced progression to an AIDS-defining illness. HIV can be detected in the lung during asymptomatic disease, as well as during the advanced stages of AIDS. With prolonged survival of HIV-infected patients, non-infectious pulmonary complications are becoming more common and can lead to respiratory compromise and failure. The pathogenesis of non-infectious pulmonary complications, following HIV infection is not fully understood, and the role that HIV-induced immunosuppression plays in the development of these complications is not known. In this review, we will discuss non-infectious pulmonary complications of HIV infection, focusing on HIV-associated malignancies of the lung, inflammatory disorders, pulmonary hypertension and the effect of antiretroviral therapy on the incidence of these diseases. The possible role that HIV plays in the pathogenesis of these pulmonary disorders is also addressed.
Export Options
About this article
Cite this article as:
Kanmogne D. Georgette, Kennedy C. Ronald and Grammas Paula, Is HIV Involved in the Pathogenesis of Non-Infectious Pulmonary Complications in Infected Patients?, Current HIV Research 2003; 1 (4) . https://dx.doi.org/10.2174/1570162033485177
DOI https://dx.doi.org/10.2174/1570162033485177 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV vaccine development
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Benefit of SERCA2a Gene Transfer to Vascular Endothelial and Smooth Muscle Cells: A New Aspect in Therapy of Cardiovascular Diseases
Current Vascular Pharmacology Physiologic Responses in Anxiety
Current Psychiatry Reviews Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Bacterial Conjunctivitis in Childhood: Etiology, Clinical Manifestations, Diagnosis, and Management
Recent Patents on Inflammation & Allergy Drug Discovery Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol
Endocrine, Metabolic & Immune Disorders - Drug Targets Glucocorticoids and Vascular Reactivity
Current Vascular Pharmacology Combining Diffusion-Weighted Imaging Patterns with ABCD2 Score Predicts Stroke Risk after Transient Ischemic Attack
Current Neurovascular Research Preface
Current Pharmaceutical Design Immunotherapy in a Rabbit Model of Alzheimer’s Disease
Drug Delivery Letters The Pathophysiology of Heart Failure in Children: The Basics
Current Cardiology Reviews New Advances in Blockade of the Renin-Angiotensin System – the Role of Direct Renin Inhibition
Current Hypertension Reviews Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Current Drug Targets - Cardiovascular & Hematological Disorders Disease Outcome, Alexithymia and Depression are Differently Associated with Serum IL-18 Levels in Acute Stroke
Current Neurovascular Research Medical Therapy of Aortic Aneurysms: A Pathophysiology-Based Approach
Current Vascular Pharmacology The Role of Endothelium in Cardiovascular Diseases: New Insights
Current Medicinal Chemistry Effect of Intranasal Administration of Galanin-like Peptide (GALP) on Body Weight and Hepatic Lipids Accumulation in Mice with Diet-induced Obesity
Current Pharmaceutical Design Role of Chymase in Preeclampsia
Current Vascular Pharmacology Novel Oral Anticoagulants in the Management of Polycythemia Vera and Essential Thrombocythemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacologic Targeting of Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets